Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist

D L Healy, Healy DL, Fraser HM, H. M. Fraser, Lawson SL, S L Lawson
British medical journal (Clinical research ed.) · 1984 · vol. 289(6454) , pp. 1267–8 · doi:10.1136/bmj.289.6454.1267 · PMID:6437510 · PMC1443483
Case report OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-23 ⓘ

A uterine fibroid shrank following the subcutaneous infusion of a LHRH agonist.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Buserelin Leiomyoma Uterine Neoplasms Adult Buserelin Buserelin Female Humans Infusions, Parenteral Leiomyoma Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
pubmed
last seen: 2026-10-08T21:58:15.129929+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00